
Zicam Products
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
In December 2015, a class-action lawsuit was filed against Zicam for allegedly deceptively marketing Zicam Pre-Cold Medicine products – including RapidMelts, Oral Mist, Ultra Crystals, Lozenges, and Chewables – as having the ability to treat cold symptoms without adequate evidence to support such claims and when scientific evidence shows that the products are “nothing more than a placebo.” (Gulkis et al v. Zicam LLC and Matrixx Initiatives, Inc., Case No. 15-cv-9843, S. D. NY.)
For more information about other class-action lawsuits regarding products claiming to treat cold symptoms and TINA.org’s coverage of them, click here.
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
May 2019: The appeal was dismissed for failure to prosecute because the objector did not pay the filing fees. December 2018: An objector filed a Notice of Appeal regarding the…
Some of the worst ads TINA.org covered this year.
The magic of Christmas makes the impossible, possible 😉🎁 #AirNZXmas
Sneaker company modifies sponsored social media post following TINA.org inquiry.
Class-action settlements that left consumers behind this year.
“Sitewide” sale didn’t include all items for sale on the site.